Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol1 passage
• A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination1 passage
• AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management1 passage
• Activated sputum eosinophils associated with exacerbations in children on mepolizumab1 passage
• Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision1 passage
• Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis1 passage
• Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial1 passage
• Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma1 passage
• Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment1 passage
• Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis1 passage
• Comparative efficacy of biologic agents for severe chronic rhinosinusitis with nasal polyps: Systematic review and network meta-analysis1 passage
• Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis1 passage
• Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis1 passage
• Dupilumab outcomes in pediatric asthma by early eosinophil status: Post hoc analysis of VOYAGE/EXCURSION1 passage
• Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: Placebo-controlled phase 2 trial1 passage
• Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma1 passage
• Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab1 passage
• Global patterns in anaphylaxis due to specific foods: A systematic review1 passage
• Helminth infections and allergic diseases: Systematic review and meta-analysis of the global literature1 passage
• How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis1 passage
• Income is an independent risk factor for worse asthma outcomes1 passage
• Individualized therapy for persistent asthma in young children1 passage
• Intradermal grass pollen immunotherapy increases T(H)2 and IgE responses and worsens respiratory allergic symptoms1 passage
• Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis1 passage
• Macrolides for asthma: A systematic review and meta-analysis of randomized trials1 passage
• Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count1 passage
• Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma1 passage
• Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab1 passage
• Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection1 passage
• Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics1 passage
• Reduction in mouse allergen exposure is associated with greater lung function growth1 passage
• Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies1 passage
• Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers1 passage
• Sublingual or subcutaneous immunotherapy for allergic rhinitis?1 passage
• The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis1 passage
• Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis1 passage
• Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials1 passage
• Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthma1 passage
• Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses1 passage